[VRAX] YoY Quarter Result on 30-Sep-2022 [#Q2]

Stock
[VRAX] Virax Biolabs Group Limited
Announcement Date
29-Sep-2022
Financial Year
2023
Quarter
30-Sep-2022 [#Q2]
Profit Trend
QoQ- -24.91%
YoY- -161.59%
Quarter Report
VRAX's Result
VRAX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
Revenue 77 6 0 14 76.51%
PBT -2,914 -1,454 -575 -390 95.49%
Tax -5 -1,451 -589 -418 -77.13%
NP -2,910 -1,444 -552 -343 103.95%
Tax Rate - - - - -
Total Cost 2,986 1,449 552 357 102.98%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
NP Margin -3,803.47 -25,062.69 0.00 -2,453.26 15.73%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 CAGR
EPS -1.64 -1.24 -0.49 -0.30 76.16%
EPS Diluted -1.64 -1.24 -0.49 -0.30 76.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.